European Journal of Clinical Oncology (EJCO)

European Journal of Clinical Oncology strives to publish highest quality articles pertaining to clinical research, which are freely accessible to one and all. The scope of the journal encompasses topics Cancer Biology, prostate cancer, colorectal cancer, cancer immuno therapy, chemotherapy, cancer radiology, therapeutic cancer, cancer pathology. Cancer poses a major challenge to development; it undermines socio-economic advances throughout the world. It is estimated that the number of patients with cancer would increase from 12.7 million in the year 2008 to 22.2 million by 2030. It is universally agreed that the condition is reaching epidemic proportions. At this time, the European Journal of Clinical Oncology is conveniently placed in the scholarly communication milieu to help counter the menace of cancer by aiding the development of novel treatment strategies, by providing novel insights into the mechanisms underlying this complex disease. It is a well-known fact that, advances in care are enabling cancer patients to live longer, and lead better quality lives. With the enhancements in the knowledge of the aetiology of cancer, survival has improved substantially. In this setting, the European Journal of Clinical Oncology provides a high-profile platform to showcase major advances in cancer research.

European Journal of Clinical Oncology (EJCO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Clinical Oncology, Cancer Biology, Prostate Cancer, Colorectal Cancer, Cancer Immunotherapy, Chemotherapy, Cancer Radiology, Therapeutic Cancer, Cancer Pathology , Online , Bi-Annual Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2732-2654, Established: 2019, Impact Factor: 0.20
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE